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Abstract
Introduction: Selenoenzymes can modulate the extent of oxidative stress, which is recognized as a key feature of
septic shock. The pathophysiologic role of erythrocyte selenium concentration in patients with septic shock remains
unknown. Therefore, the objective of this study was to evaluate the association of erythrocyte selenium concentration
with glutathione peroxidase (GPx1) activity, GPx1 polymorphisms and with ICU and hospital mortality in septic
shock patients.
Methods: This prospective study included all patients older than 18 years with septic shock on admission or during
their ICU stay, admitted to one of the three ICUs of our institution, from January to August 2012. At the time of the
patients’ enrollment, demographic information was recorded. Blood samples were taken within the first 72 hours of
the patients’ admission or within 72 hours of the septic shock diagnosis for determination of selenium status, protein
carbonyl concentration, GPx1 activity and GPx1 Pro198Leu polymorphism (rs 1050450) genotyping.
Results: A total of 110 consecutive patients were evaluated. The mean age was 57.6 ± 15.9 years, 63.6% were male.
Regarding selenium status, only erythrocyte selenium concentration was lower in patients who died in the ICU. The
frequencies for GPx1 Pro198Leu polymorphism were 55%, 38% and 7% for Pro/Pro, Pro/Leu and Leu/Leu, respectively.
In the logistic regression models, erythrocyte selenium concentration was associated with ICU and hospital mortality in
patients with septic shock even after adjustment for protein carbonyl concentration and acute physiology and chronic
health evaluation II score (APACHE II) or sequential organ failure assessment (SOFA).
Conclusions: Erythrocyte selenium concentration was a predictor of ICU and hospital mortality in patients with septic
shock. However, this effect was not due to GPx1 activity or Pro198Leu polymorphism.
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Introduction
Overall cellular oxidative burden is regulated by a balance
between the rates of reactive oxygen species (ROS) gener-
ation and a variety of antioxidant enzymes/pathways.
ROS are generally believed to be harmful because they
cause oxidative damage to DNA, protein, lipids and other
macromolecules. However, at nanomolar concentrations,
these free radicals may play an important role in physio-
logical processes, for example, by functioning as a second
messenger in signal transduction pathways. Thus, ROS
can be deleterious through modulation of signaling net-
works [1,2]. In addition, oxidative stress and mitochon-
drial dysfunction have been recognized as key features of
severe sepsis and septic shock [3,4]. For this reason, in the
last decade, antioxidant supplementation in critically ill
patients has been evaluated [5,6]. Heyland et al. showed in
a meta-analysis that antioxidants, particularly high-dose
intravenous selenite, as monotherapy or in combination
with other antioxidants, are a safe strategy and are associ-
ated with a trend toward reduction in outcomes, including
mortality [5].
Selenium is an essential trace element, and its incorp-
oration into selenoproteins is associated with biological
functions. For instance, the increased glutathione perox-
idase (GPx) activity is known to increase antioxidant
defenses and reduce oxidative damage [7]. The finding
of low plasma or whole blood selenium concentrations
in critically ill patients has encouraged several selenium
supplementation trials. Despite promising results, the
optimal dose, method and time of administration remain
to be established [8-11]. It is probable that the nutritional
selenium status previous to intensive care unit (ICU)
admission and specific patient characteristics could influ-
ence the response to selenium supplementation.
Usually, nutritional status of selenium is commonly
assessed by direct measurement of plasma selenium con-
centration or indirectly by measuring the activity of the
GPx [12]. However, studies that evaluated patients with
systemic inflammatory response, plasma selenium con-
centration showed controversial results [13-15]. Heyland
et al. in the REDOX study showed that baseline median
plasma selenium levels were within normal limits in
patients with multiple organ dysfunction [15]. In a study
involving 91 critically ill patients, Stefanowicz et al. recently
showed that plasma selenium is affected by the inflam-
matory response while erythrocyte selenium concentration
is unaffected and can be used to reliably assess selenium
status across a wide range of selenium intakes [12]. In
addition, erythrocyte selenium concentrations reflect
longer term nutritional status due to its incorporation
in erythrocyte synthesis [16].
Eight GPx enzymes are expressed in humans, and several
studies have demonstrated their association with health.
Some GPxs (GPx1, GPx2, GPx3 and GPx4) are selenium-
containing enzymes and, therefore, are implicated in dif-
ferent typical functions of selenoproteins, including
inflammation, angiogenesis, and endothelial function
[17]. However, the most studied action of GPxs is related
to oxidative stress. Indeed, to protect against oxidative
stress, GPxs work in a coordinated manner with other
enzymatic antioxidants (superoxide dismutase, and cata-
lase) to convert ROS to H2O.
GPx1 is a selenoprotein that consists of four 22 kDa
subunits, each of which contains one atom of selenium.
Some polymorphisms have been found in human GPx1,
and Pro198Leu polymorphism is thought to be functional
[18]. Despite the conflicting results, individuals carrying
the variant alleles seem to have an altered response to
selenium supplementation [19].
Therefore, the objective of this study was to evaluate
the association of erythrocyte selenium concentration
with GPx1 activity, Pro198Leu polymorphism and with
both ICU and hospital mortality in septic shock patients.
Materials and methods
All procedures were approved by the Ethics Committee
of Botucatu Medical School (4063/2011), and have
therefore been performed in accordance with the ethical
standards laid down in the 1964 Declaration of Helsinki
and its later amendments. Written informed consent
was obtained from all patients prior to their inclusion in
the study. All patients older than 18 years with septic
shock on admission or septic shock during their ICU
stay who were admitted to one of the three 28-bed ICUs
at our hospital between January and August 2012 were
prospectively evaluated.
At the time of the patients’ enrollment, demographic
information, the acute physiology and chronic health
evaluation (APACHE II) score and the sequential organ
failure assessment (SOFA) score were recorded. Blood
samples were taken within the first 72 hours of the
patients’ admission or within 72 hours after septic shock
diagnosis for determination of selenium status, protein
carbonyl concentration, GPx1 activity and Pro198Leu
polymorphism genotyping.
Septic shock was defined as an infection-induced sys-
temic inflammatory response with systolic blood pressure
lower than 90 mmHg or a mean arterial pressure lower
than 70 mmHg requiring the introduction of vasopressor
drugs [20]. All patients were followed during their ICU
and hospital stay. The ICU and hospital mortality were
recorded.
Laboratory analysis
Total serum levels of sodium, potassium, magnesium,
total calcium, phosphorus, C-reactive protein (CRP),
albumin, creatinine and urea were measured using the dry
chemistry method (Ortho Clinical Diagnostics VITROS
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950™; Johnson & Johnson, New Brunswick, NJ, USA),
and lactate was measured using Roche OMNI S™ Blood
Gas Analyzer (Roche Diagnostics, Basel, Switzerland).
Hemograms were performed with a Coulter STKS hema-
tology autoanalyzer (Coulter Electronics Ltd., Luton,
Bedfordshire, UK).
Protein carbonyl determination
Measurement of protein carbonyl groups is the most
widely utilized measure of protein oxidation [21]. There-
fore, protein carbonyl levels were analyzed based on the
reaction with dinitrophenylhydrazine (DNPH) and the
formation of a Schiff base according to the method
described by Reznick and Packer [22].
Selenium status and GPx1 activity
Erythrocyte and plasma selenium concentrations were
measured using hydride generation flame atomic absorp-
tion spectrometry as previously described [19,23]. The
references for plasma selenium concentration were values
between 1.07 to 1.27 μmol/L (84 to 100 μg/L), and those
for erythrocyte selenium concentration were values be-
tween 0.76 to 1.52 μmol/L (60 to 120 μg/L) [24,25].
The glutathione peroxidase activity of red blood cell
hemolysate was assessed using the method described
by Paglia and Valentine using the Ransel kit (Randox
Laboratories Ltd, Crumlin, County Antrim, UK) [26].
Pro198Leu polymorphism
The DNA was isolated from frozen blood samples with
the illustra blood genomicPrep Mini Spin Kit (GE
Healthcare, Waukesha, WI, USA). Polymerase chain
reaction (PCR) primers based on the human GPx1 gene
sequence flanking the 198 polymorphism (rs 1050450)
(GPx1 forward primer, 50-TGCCCCTACGCAGGTAC
A-30; GPx1 reverse primer, 50-TCCCAAATGACAAT
GACACAG-30) were used to generate a 337-bp ampli-
fication product [24]. PCR was performed following a
previously described method [27]. The analyses were
performed in duplicate.
Statistical analysis
Data are expressed as the mean ± standard deviation
(SD) or the median (including the lower and upper quar-
tiles). Comparisons between two groups for continuous
variables were performed using Student’s t test and
between three groups, one-way ANOVA for parameters
with normal distribution. Comparisons between two groups
for continuous variables were performed using Mann-
Whitney test and between three groups, Kruskal-Wallis
followed by Dunn’s post hoc test for parameters with
non-normal distribution. Fisher’s test or the χ2 test was
used for all categorical data. Spearman correlation was
used to evaluate the association of continuous variables.
Logistic regression models were used to predict both
ICU and hospital mortality in patients with septic shock.
The primary outcome was ICU mortality, and the second-
ary outcome was hospital mortality. Erythrocyte selenium
concentration was tested as a continuous independent
variable. Parameters that exhibited significant difference
in the univariate analysis were included as independent
factors in logistic regression models. The only exceptions
were variables with high collinearity among them (urea,
albumin, and lactate). Data analysis was performed using
SigmaPlot software for Windows v12.0 (Systat Software
Inc., San Jose, CA, USA). P values lower than 0.05 were
considered statistically significant.
Results
One hundred and ten consecutive patients were evaluated.
The mean age was 57.6 ± 15.9 years, 63.6% were male,
the median ICU and hospital stays were 7 (3 to 13)
and 13 (4 to 22) days, respectively. The mortality rate
during the ICU stay was 54.5%, and 63.6% died during
hospital stay. The demographic, clinical and laboratory
data are presented in Table 1. Patients who died during
their ICU stay exhibit higher serum lactate, urea and pro-
tein carbonyl concentrations, as well as higher APACHE
II and SOFA scores. These patients also exhibited lower
serum albumin levels.
In our study, the erythrocyte GPx activity was 30.6
(24.0 to 38.4 U/gHb). About 33.3% of the patients pre-
sented lower GPx activity than reference values (27.5 to
73.6 U/gHb). However, GPx activity was not associated
with mortality. Regarding selenium status, only erythrocyte
selenium concentration was lower in septic patients who
died in the ICU (Table 1). Importantly, both survivors and
nonsurvivors had markedly low selenium concentration.
Our data showed a correlation between erythrocyte
selenium levels and GPx (r = 0.193; P = 0.05), at the limit
of statistic significance. On the other hand, there is no
correlation between GPx and protein carbonyl values
(r = -0.175; P = 0.09) and erythrocyte selenium levels
and protein carbonyl values (r = -0.153; P = 0.133).
Genotype analysis was performed in 104 patients due to
technical problems with the other samples. The genotype
frequencies for GPx1 Pro198Leu polymorphism were
55%, 38% and 7% for Pro/Pro, Pro/Leu and Leu/Leu,
respectively. These frequencies are consistent with those
expected under the Hardy-Weinberg equilibrium. The
erythrocyte selenium concentration, GPx1 activity, protein
carbonyl and mortality according to Pro198Leu poly-
morphism genotype are presented in Table 2. Only GP×1
activity was different between groups and higher in Leu/
Leu genotype. In addition, there was no association be-
tween GP×1 activity, erythrocyte selenium concentration
and protein carbonyl when each genotype group was
analyzed separately (Table 3).
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Table 1 Demographic, clinical and laboratory data of 110 patients with septic shock
Variable ICU mortality P value
Yes (n = 60) No (n = 50)
Age, (years) 58.8 ± 15.7 56.2 ± 16.2 0.395
Male, number (%) 36 (60%) 34 (68%) 0.503
SOFA score 10.0 (7.3 - 12.0) 9.0 (7.0 - 10.0) 0.032
APACHE II score 21.9 ± 7.4 17.7 ± 6.7 0.003
Sepsis focus, number (%)
Respiratory 34 (57) 27 (54) 0.193
Soft tissue 8 (13) 2 (4)
Urinary 4 (7) 7 (14)
Abdominal 12 (20) 9 (18)
Others 2 (3) 5 (10)
MV, number (%) 58 (97) 38 (76) 0.003
RBC transfusion number (%) 37 (62) 28 (56) 0.684
Lactate, (mmol/L) 2.2 (1.3 - 3.8) 1.6 (1.1 - 2.2) 0.007
Hemoglobin, (g/dl) 10.9 ± 2.3 11.2 ± 2.4 0.534
Hematocrit, (%) 32.8 ± 6.7 33.8 ± 7.2 0.429
Leucocytes, (103/mm3) 16.1 (10.6 - 21.1) 12.7 (9.2 - 17.5) 0.070
Sodium, (mmol/L) 142 (137 - 147) 140 (137 - 146) 0.286
Potassium, (mmol/L) 4.2 (3.8 - 4.7) 4.1 (3.6 - 4.8) 0.631
Phosphorus, (mg/dl) 4.4 (3.4 - 5.4) 3.7 (2.8 - 4.6) 0.073
Total calcium, (mg/dl) 7.6 (7.0 - 8.3) 8.0 (7.5 - 8.3) 0.115
Magnesium, (mg/dl) 2.1 (1.8 - 2.3) 1.9 (1.7 - 2.2) 0.180
Glycemia, (mg/dl) 180 (121 - 247) 177 (129 - 248) 0.977
CRP, (mg/dl) 23.0 (8.0 - 31.5) 23.0 (6.5 - 36.0) 0.511
Albumin, (g/dl) 2.0 (1.7 - 2.5) 2.6 (2.1 - 3.0) 0.002
Urea, (mg/dl) 96.5 (52.3 - 138.5) 54.5 (42.0 - 92.5) 0.004
Creatinine, (mg/dl) 1.3 (0.7 - 2.5) 1.1 (0.6 - 2.5) 0.418
Erythrocyte Se, (μmol/L) 0.38 ± 0.15 0.46 ± 0.14 0.005
Plasma Se, (μmol/L) 0.30 ± 0.12 0.29 ± 0.11 0.787
Protein carbonyl, (nmol/ml) 14.6 (5.2 - 26.1) 5.4 (3.4 - 21.0) 0.021
GPx1, (U/g Hb) 30.1 (20.8 - 37.1) 31.2 (26.1 - 39.0) 0.301
Data are expressed as the mean ± standard deviation (SD), median (including the lower and upper quartiles) or percentage. ICU, intensive care unit; SOFA,
sequential organ failure assessment; APACHE II, acute physiology and chronic health evaluation II; MV, mechanical ventilation; RBC, red blood cell; CRP, C-reactive
protein; Se, selenium concentration; GPx1, glutathione peroxidase activity.
Table 2 Erythrocyte selenium concentration, GPx1 activity, protein carbonyl and mortality according to Pro198Leu
polymorphism genotype
Variables Pro/Pro (n = 57) Pro/Leu (n = 40) Leu/Leu (n = 7) P value
Erythrocyte Se, (μmol/L) 0.41 ± 0.15 0.42 ± 0.14 0.46 ± 0.12 0.655
Protein carbonyl, (nmol/ml) 13.5 (4.6 - 24.2) 7.5 (4.4 - 25.7) 5.3 (3.1 - 17.5) 0.403
GPx1, (U/g Hb) 28.5 (19.8 - 36.7) 31.1 (27.7 - 41.0) 35.9 (24.7 - 51.5) 0.045
SOFA score 8.8 ± 2.6 10.4 ± 4.3 9.1 ± 1.9 0.067
ICU mortality, number (%) 27 (47) 26 (65) 4 (57) 0.227
Hospital mortality, number (%) 31 (54) 30 (75) 5 (71) 0.105
Data are expressed as the mean ± standard deviation (SD), median (including the lower and upper quartiles) or percentage. GPx1, glutathione peroxidase activity;
Se, selenium concentration; SOFA, sequential organ failure assessment; ICU, intensive care unit.
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In the logistic regression models, the erythrocyte selen-
ium concentration was associated with ICU and hospital
mortality in patients with septic shock even after adjust-
ment for protein carbonyl concentrations, SOFA or APA-
CHE II scores (Table 4).
Discussion
The aim of this study was to evaluate the association of
erythrocyte selenium concentration with GPx1 activity,
Pro198Leu polymorphism and ICU and hospital mortality
in septic shock patients. Erythrocyte selenium concen-
tration was a predictor of mortality in these patients.
However, this effect was not due to GPx1 activity or
Pro198Leu polymorphism.
Septic shock is the major cause of death in the ICU,
and despite increased knowledge of the pathogenesis
of sepsis and the creation of ‘bundles’ of care by the
international consortium ‘Surviving Sepsis Campaign’,
the septic shock mortality rate remains high [28-30].
Oxidative stress plays an important role in the devel-
opment of organ dysfunction and multiple organ failure in
critically ill patients [4]. In our study, patients who died
during the ICU stay exhibit higher protein carbonyl con-
centrations, a biomarker of protein oxidative damage [21].
These data reinforce the importance of oxidative stress in
septic patients. For this reason, in the last decade, trials
with trace elements and vitamin supplementation for
critically ill patients have been performed. Among these
micronutrients, selenium is particularly important, and
despite promising results, further studies are needed to
determine the optimal dose and best method and time
of administration [5,6,31]. We believed that nutritional
selenium status previous to ICU admission and GP×1
Pro198Leu polymorphism could influence the response
of selenium supplementation.
Selenium is an essential micronutrient that functions
as a component of many selenoproteins in antioxidant
and redox reactions. For instance, mortality in Keshan
disease is considered to be related to a selenium deficiency
associated with an oxidative aggression due to coxsackie
infection leading to lethal cardiomyopathy [32]. Therefore,
having a previous selenium deficiency could predispose to
death patients suffering from septic shock [33].
More than 25 selenoprotein families have been identi-
fied, including glutathione peroxidases, phosphohydroxyl-
glutathione peroxidase and thioredoxin reductases [7,34].
It is important to note that in these antioxidant enzymes,
there is always one selenium atom, in the form of seleno-
cysteine, at the active site required for its activity [35,36].
In healthy individuals, selenoprotein P is the major seleno-
protein in plasma, accounting for 52% of the total plasma
selenium. Glutathione peroxidase accounts for another
39%, albumin for 9% and free selenium for less than 1% of
total selenium [35].
Selenium status varies by country and corresponds to
dietary selenium intake and dietary supplements. For
instance, in the USA, 50% of the population takes dietary
supplements [37]. Therefore, it is difficult to compare
plasmatic selenium levels between different studies. In
critically ill patients, it is postulated that plasma selenium
could be affected by the inflammatory response. However,
in the REDOX trial, patients with sepsis presented the
same amount of selenium as controls in the plasma [15].
Importantly, similar to our data, other studies showed that
critical patients presented lower plasmatic selenium levels
[38-40]. The reasons for these discrepancies remain to be
elucidated.
Stefanowicz et al. showed recently in a noninflamed
population a strong positive correlation between erythro-
cyte and plasma selenium concentration that was not
Table 3 Correlation among erythrocyte selenium concentration, GPx1 activity and protein carbonyl according to
Pro198Leu polymorphism genotype
Pro/Pro Pro/Leu Leu/Leu
Erythrocyte selenium concentration (μg/L)
r P r P r P
GPx1, (U/g Hb) 0.231 0.110 0.145 0.389 0.214 0.602
Protein carbonyl, (nmol/ml) -0.219 0.121 -0.080 0.650 -0.179 0.660
GPx1, glutathione peroxidase activity.
Table 4 Logistic regression models for ICU and hospital mortality in 110 patients with septic shock
ICU mortality Hospital mortality
Odds ratio 95% CI P value Odds ratio 95% CI P value
Erythrocyte Se 0.950 0.916 - 986 0.007 0.955 0.920 - 0.992 0.017
Erythrocyte Se* 0.914 0.869 - 0.962 <0.001 0.927 0.883 - 0.973 0.002
Erythrocyte Se** 0.945 0.907 - 0.983 0.006 0.950 0.912 - 0.989 0.013
*Adjusted by protein carbonyl concentration, and acute physiology and chronic health evaluation II (APACHE II); **adjusted by protein carbonyl concentration and
sequential organ failure assessment (SOFA). ICU, intensive care unit; Se, selenium concentration.
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found in inflamed critically ill patients [12]. In addition, in
these patients, plasma selenium was low and erythrocyte
selenium concentration was normal. Their results suggest
that plasma selenium is affected by the inflammatory
response while erythrocyte selenium concentration is
unaffected and can be used to reliably assess selenium
status [12]. In our study, both survivors and nonsurvivors
had low selenium concentration. Importantly, this low
selenium concentration is in accord with the observed
mortality. However, only erythrocyte selenium concen-
trations were associated with both ICU and hospital
mortality in septic shock patients.
To investigate why erythrocyte selenium concentrations
were associated with mortality in our patients, we also
evaluated GPx1 activity and its Pro198Leu polymorphism.
This polymorphism is associated with a cytidine-to-
thymidine substitution in exon 2 of the gene, promoting
an amino acid change from proline to leucine at codon
198 [19]. Some studies revealed that the Leu allele is
associated with lower responsiveness of the enzyme
activity to selenium supplementation [41,42]. However,
others did not observe this association [43]. In our study,
GPx1 activity was higher in patients carrying the variant
allele. However, we did not find any correlation between
erythrocyte selenium concentration, GPx1 activity and
protein carbonyl in the different genotypes. In addition,
the different genotypes did not influence mortality in our
patients.
It is important to note that there are other polymor-
phisms in the GPx gene that could also influence its ac-
tivity, and these were not evaluated in this research. In
addition, the association of thioredoxin reductase and
selenoprotein P with erythrocyte selenium concentration
was not previously evaluated in septic shock patients.
We should consider the limitations of this study. We
only included patients from a single medical center. In
addition, our sample size was relatively small. Finally, we
did not measure whole blood selenium levels, only
plasma and erythrocyte selenium concentration.
Conclusions
In conclusion, erythrocyte selenium concentration was a
predictor of ICU and hospital mortality in patients with
septic shock. However, this effect was not due to GPx1
activity or Pro198Leu polymorphism.
Key messages
 Erythrocyte selenium concentration is a predictor
of ICU and hospital mortality in patients with
septic shock.
 Erythrocyte selenium concentration effect as a
predictor of mortality was not due to influence
on GPx1 activity or Pro198Leu polymorphism.
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